Veracyte Inc at Credit Suisse Healthcare Conference Transcript
So in our next session, we have Veracyte, Marc Stapley, CEO; Rebecca Chambers, CFO. Thank you both for joining us. I'm Dan Leonard, the diagnostics analyst at Credit Suisse and happy to kick things off and learn more about Veracyte.
Marc, I think you wanted to start with the safe harbor statement?
Yes. Thanks, Dan, and thanks for having us here today. It's a real pleasure to be here at this conference. And yes, I would like to refer investors to our safe harbor statement that can be found on our corporate website, in our corporate presentation, www.veracyte.com, to the extent we make forward-looking statements that are intended to be covered by the safe harbor statement.
Questions & Answers
Look forward to that. So before we get off and start talking about forward-looking statements, Marc, can you give us a brief overview of Veracyte for folks who aren
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
